Lonza Group Ltd

O6Z

Company Profile

  • Business description

    Lonza Group is a contract development and manufacturing organization, or CDMO. It operates under four segments: small molecules, biologics, cell & gene, and capsules & health ingredients. Lonza derives its revenue primarily from long-term supply agreements with pharmaceutical customers. The company provides a range of development and manufacturing services throughout the entire lifecycle of a product from drug research to commercial supply. The majority of Lonza's customers are pharmaceutical and biotechnology companies, academic institutions, and government research organizations.

  • Contact

    Muenchensteinerstrasse 38
    Basel4002
    CHE

    T: +41 613168111

    E: [email protected]

    https://www.lonza.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Diagnostics & Research

    Fiscal Year End

    31 December 2025

    Employees

    18,686

Stocks News & Analysis

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,775.004.400.05%
CAC 407,742.2457.560.75%
DAX 4023,699.12182.890.78%
Dow JONES (US)42,515.09317.300.75%
FTSE 1008,875.2224.590.28%
HKSE24,060.99168.430.70%
NASDAQ19,701.21294.391.52%
Nikkei 22538,311.33477.081.26%
NZX 50 Index12,690.13137.261.09%
S&P 5006,033.1156.140.94%
S&P/ASX 2008,548.401.000.01%
SSE Composite Index3,388.7311.730.35%

Market Movers